نتایج جستجو برای: Radiopeptide

تعداد نتایج: 77  

2011
Amir Sabet Hojjat Ahmadzadehfar Ulrich Herrlinger Winfried Wilinek Hans-Jürgen Biersack Samer Ezziddin

A patient with anaplastic meningioma and lung metastases resistant to conventional treatment underwent radiopeptide therapy with 177Lu- DOTA-octreotate in our institute. The treatment resulted in significant improvement in patient's quality of life and inhibition of tumor progression. This case may eventually help to establish the value of radiopeptide therapy in patients with this rare condition.

2016
J. C. Haeck K. Bol C. M. A. de Ridder L. Brunel J. A. Fehrentz J. Martinez W. M. van Weerden M. R. Bernsen M. de Jong J. F. Veenland

BACKGROUND As model system, a solid-tumor patient-derived xenograft (PDX) model characterized by high peptide receptor expression and histological tissue homogeneity was used to study radiopeptide targeting. In this solid-tumor model, high tumor uptake of targeting peptides was expected. However, in vivo SPECT images showed substantial heterogeneous radioactivity accumulation despite homogenous...

Journal: :Nature Reviews Clinical Oncology 2012

Journal: :Journal of Nuclear Medicine 2011

Journal: :iranian journal of pharmaceutical research 0
sepideh khoshbakht department of radiopharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran, davood beiki research center for nuclear medicine, tehran university of medical sciences, tehran, iran. parham geramifar research center for nuclear medicine, tehran university of medical sciences, tehran, iran. farzad kobarfard department of pharmaceutical chemistry, school of pharmacy, phytochemistry research center, shahid beheshti university of medical sciences, tehran, iran, omid sabzevari department of toxicology & pharmacology, faculty of pharmacy, and toxicology and poisoning research centre, tehran university of medical sciences, tehran, iran, mohsen amini department of medicinal chemistry, and drug design and development research center, faculty of pharmacy, tehran university of medical sciences, tehran, iran,

introduction: a noninvasive method of detecting exposure of phosphatidylserine (ps) on the external surface of the plasma membrane such as nuclear imaging could assist the diagnosis and therapy of apoptosis related pathologies. the most studied imaging agent for apoptosis is annexin v so far. because of limitations of annexin v other agents have been introduced such as small peptides and molecu...

Journal: :iranian journal of pharmaceutical research 0
danial shamshirian department of radiopharmacy, school of pharmacy, tehran university of medical sciences, tehran, iran mostafa erfani radiation application research school, nuclear science and technology research institute (nstri), tehran, iran davood beiki research center for nuclear medicine, tehran university of medical sciences, tehran, iran maliheh hajiramazanali department of radiopharmacy, school of pharmacy, tehran university of medical sciences, tehran, iran. babak fallahi research center for nuclear medicine, tehran university of medical sciences, tehran, iran

melanocortin-1 (mc1) receptor is an attractive melanoma-specific target for the development of α-msh peptide based imaging and therapeutic agents. in this work a new lactam bridge α-msh analogue was synthesized and radiolabeled with 99mtc via hynic chelator and tricine as co-ligand. also, stability in human serum, receptor bound internalization and tissue biodistribution in tumor bearing nude m...

2014
Andreas Wicki Damian Wild Vincent Prêtre Rosalba Mansi Annette Orleth Jean-Claude Reubi Christoph Rochlitz Christoph Mamot Helmut R Mäcke Gerhard Christofori

BACKGROUND Neuroendocrine tumors are well vascularized and express specific cell surface markers, such as somatostatin receptors and the glucagon-like peptide-1 receptor (GLP-1R). Using the Rip1Tag2 transgenic mouse model of pancreatic neuroendocrine tumors (pNET), we have investigated the potential benefit of a combination of anti-angiogenic treatment with targeted internal radiotherapy. MET...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید